Loading...
XNYS
PHR
Market cap1.22bUSD
Dec 05, Last price  
20.29USD
1D
-1.27%
1Q
-27.87%
IPO
-15.46%
Name

Phreesia Inc

Chart & Performance

D1W1MN
XNYS:PHR chart
P/E
P/S
2.90
EPS
Div Yield, %
Shrs. gr., 5y
23.19%
Rev. gr., 5y
27.46%
Revenues
420m
+17.83%
79,834,00099,888,805124,784,000148,677,000213,233,000280,910,000356,299,000419,813,000
Net income
-59m
L-57.24%
-18,192,000-15,062,007-20,293,000-27,292,000-118,161,000-176,146,000-136,885,000-58,527,000
CFO
32m
P
-11,142,000-2,129,926826,0002,890,000-74,710,000-90,123,000-32,378,00032,381,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
IPO date
Jul 18, 2019
Employees
1,576
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑012024‑012023‑012022‑012021‑012020‑012019‑012018‑01
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT